Report on a new high-affinity RNA aptamer that blocks endocan–VEGF-A interactions and reduces pathological angiogenesis in preclinical models.
Key Takeaways
- Histological staining and hemoglobin quantification confirmed its anti-angiogenic effects
- It is citable and carries a permanent DOI
- This version is subject to further edits and will be replaced automatically by the final Version of Record